Xencor | XNCR - Modal Pinjaman





Modal Pinjaman Perubahan Tanggal
AbbVie USD 62.97B 12M 2025-09
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Amgen USD 50B 2.43B 2025-12
Arrowhead Research USD 538.1M 323.22M 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Biogen USD 6.29B 1.4M 2025-09
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Cytokinetics USD 1.12B 957.23M 2025-12
GlaxoSmithKline GBP 14.71B 186M 2025-12
J&J USD 39.44B 30M 2025-12
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
MacroGenics USD 70M 256K 2025-12
Merck USD 39.97B 6B 2025-09
Novartis USD 29.59B 5.35B 2025-12
Pfizer USD 57.41B 93M 2025-09
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Xencor USD 76.48M 11.29M 2025-12